Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas, T
Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. [electronic resource] - European journal of internal medicine Mar 2009 - 197-200 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article
1879-0828
10.1016/j.ejim.2008.06.009 doi
Adult
Aged
Atorvastatin
Cholesterol, HDL--blood
Cholesterol, LDL--blood
Clofibric Acid--administration & dosage
Diabetes Mellitus, Type 2--blood
Dyslipidemias--blood
Female
Follow-Up Studies
Heptanoic Acids--administration & dosage
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage
Male
Middle Aged
Prospective Studies
Pyrroles--administration & dosage
Triglycerides--blood
Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. [electronic resource] - European journal of internal medicine Mar 2009 - 197-200 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article
1879-0828
10.1016/j.ejim.2008.06.009 doi
Adult
Aged
Atorvastatin
Cholesterol, HDL--blood
Cholesterol, LDL--blood
Clofibric Acid--administration & dosage
Diabetes Mellitus, Type 2--blood
Dyslipidemias--blood
Female
Follow-Up Studies
Heptanoic Acids--administration & dosage
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage
Male
Middle Aged
Prospective Studies
Pyrroles--administration & dosage
Triglycerides--blood